mild to moderate

Showing 1 - 2 of 2

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Russian Clinical and Research Center of Gerontology of Pirogov

Completed
  • COVID-19
  • Mild to Moderate
  • Baricitinib Oral Tablet
  • +3 more
  • Moscow, Russian Federation
  • +1 more
Mar 31, 2022

Alzheimer, Mild to Moderate Trial in Beer Yaakov (Sham-NICE-System, NICE-System)

Completed
  • Alzheimer Disease
  • Mild to Moderate
  • Sham-NICE-System
  • NICE-System
  • Beer Yaakov, Israel
    Assaf-Harofeh Medical Center
Mar 26, 2013